The study, conducted by the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury in Virginia, and the Army Research and Materiel Command in Maryland, is expected to run for at least 18 months. It will include about 300 participants, mostly soldiers and Marines, and will build upon other ongoing studies on TBI treatment, said Col. Richard Ricciardi, director of the research evaluation and quality assurance and surveillance directorate at Defense Centers of Excellence.

TREATMENT: Pentagon focuses on traumatic brain injury

Individuals getting the experimental treatment will breathe 100% oxygen while inside the hyperbaric chamber at 1.35 atmospheres of pressure — about the same amount of pressure you would feel if you dived 20 to 25 feet below water. The theory is that the pressure created by the HBOT chamber causes oxygen in the blood to dissolve, allowing more oxygen to flow through the body and repair damaged tissue.

A control group will feel a similar amount of pressure inside the chamber, but will breathe regular air, which will dissolve at the regular rate, he said.

The hyperbaric chambers will hold three to 16 participants. Each person will be asked to sit in the HBOT chamber for one hour a day, five days a week for 40 sessions. The study is primarily looking at service members who suffered a TBI about four to six months ago, and are going through the healing process, he said.

Soldiers interested in participating in the study should talk to their health care provider to see if there are clinical trials available in their area and whether they are a candidate for those trials.

Five sites will participate in the study: Fort Carson, Colo.; Camp Pendleton, Calif.; Camp Lejeune, N.C.; Brooks City-Base, Texas; and possibly Fort Hood, Texas, although negotiations are still ongoing there, Ricciardi said.

Source: USA Today Military News

Tags: HBOT chamber, HBOT therapy, hyperbaric chamber, Hyperbaric Therapy

This entry was posted on Thursday, April 8th, 2010 at 1:27 pm and is filed under HBOT - Therapy. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.